{"id":"W3115714183","doi":"10.1016/j.jaip.2020.12.035","title":"GINA 2020: Potential Impacts, Opportunities, and Challenges for Primary Care","year":2020,"lang":"en","type":"article","venue":"The Journal of Allergy and Clinical Immunology In Practice","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"Grifols; Menarini Group; AstraZeneca Australia; Sanofi Australia; Mylan; AstraZeneca; Chiesi Farmaceutici; Respiratory Effectiveness Group; Covis Pharma; Boehringer Ingelheim; GlaxoSmithKline Australia; Sanofi; GlaxoSmithKline; Regeneron Pharmaceuticals; Novo Nordisk; Teva Pharmaceutical Industries; Novartis; Pfizer","keywords":"Asthma; Medicine; Asthma management; Primary care; Inhaled corticosteroids; Asthma exacerbations; Intensive care medicine; Pediatrics; Family medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":{"nature":"Reinstatement","reason":"Date of Article and/or Notice Unknown;Notice - Limited or No Information;Removed;Retract and Replace;Temporary Removal;","date":"12/26/2020 0:00","openalex_flagged":false},"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021988,0.0007195639,0.0009295869,0.0008852379,0.00195639,0.006477517,0.003437563,0.008564928,0.04140332],"category_scores_gemma":[0.02281385,0.0003594113,0.001554164,0.001128437,0.00261901,0.004119924,0.008429375,0.007541893,0.006588386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005769227,"about_ca_system_score_gemma":0.04930092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02275655,"about_ca_topic_score_gemma":0.04727682,"domain_scores_codex":[0.9928516,0.003172624,0.0002427532,0.000306064,0.001150991,0.002275907],"domain_scores_gemma":[0.9607985,0.005208945,0.001279953,0.0003994481,0.002964989,0.02934811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007280808,0.0005340433,0.01972594,0.00271203,0.0001240928,0.0006521711,0.0007266633,0.0007288642,0.0007419143,0.04283202,0.7239264,0.2065679],"study_design_scores_gemma":[0.0005291917,0.0008585081,0.04284571,0.006181072,0.000167886,0.0005347526,0.004515145,0.001585527,0.0003681179,0.03347006,0.9088215,0.0001225009],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.00930714,0.02763184,0.0008649881,0.9300395,0.01060096,0.0001065491,0.002116117,0.000407935,0.01892489],"genre_scores_gemma":[0.2837783,0.06939388,0.0239115,0.5767792,0.0183451,0.0007696264,0.007219144,0.0006052331,0.01919802],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.04140332,"threshold_uncertainty_score":0.1385079,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07297312390137087,"score_gpt":0.3514875849199509,"score_spread":0.27851446101858,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}